nodes	percent_of_prediction	percent_of_DWPC	metapath
Fidaxomicin—ABCB1—Mitomycin—stomach cancer	0.475	0.581	CbGbCtD
Fidaxomicin—ABCB1—Irinotecan—stomach cancer	0.122	0.149	CbGbCtD
Fidaxomicin—ABCB1—Docetaxel—stomach cancer	0.0892	0.109	CbGbCtD
Fidaxomicin—ABCB1—Doxorubicin—stomach cancer	0.0665	0.0815	CbGbCtD
Fidaxomicin—ABCB1—Methotrexate—stomach cancer	0.0644	0.0789	CbGbCtD
Fidaxomicin—Megacolon—Irinotecan—stomach cancer	0.016	0.0872	CcSEcCtD
Fidaxomicin—Megacolon—Methotrexate—stomach cancer	0.00798	0.0435	CcSEcCtD
Fidaxomicin—Intestinal obstruction—Irinotecan—stomach cancer	0.00386	0.021	CcSEcCtD
Fidaxomicin—Anaemia—Floxuridine—stomach cancer	0.00312	0.017	CcSEcCtD
Fidaxomicin—Platelet count decreased—Capecitabine—stomach cancer	0.00296	0.0161	CcSEcCtD
Fidaxomicin—Nervous system disorder—Floxuridine—stomach cancer	0.0027	0.0147	CcSEcCtD
Fidaxomicin—Intestinal obstruction—Docetaxel—stomach cancer	0.00267	0.0145	CcSEcCtD
Fidaxomicin—Intestinal obstruction—Capecitabine—stomach cancer	0.00258	0.0141	CcSEcCtD
Fidaxomicin—Anaemia—Mitomycin—stomach cancer	0.00245	0.0133	CcSEcCtD
Fidaxomicin—Decreased appetite—Floxuridine—stomach cancer	0.00239	0.013	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Floxuridine—stomach cancer	0.00225	0.0123	CcSEcCtD
Fidaxomicin—Abdominal pain—Floxuridine—stomach cancer	0.00218	0.0118	CcSEcCtD
Fidaxomicin—Hypersensitivity—Floxuridine—stomach cancer	0.00203	0.011	CcSEcCtD
Fidaxomicin—Dyspnoea—Mitomycin—stomach cancer	0.00192	0.0105	CcSEcCtD
Fidaxomicin—Gastrointestinal haemorrhage—Irinotecan—stomach cancer	0.00191	0.0104	CcSEcCtD
Fidaxomicin—Decreased appetite—Mitomycin—stomach cancer	0.00188	0.0102	CcSEcCtD
Fidaxomicin—Gastrointestinal haemorrhage—Fluorouracil—stomach cancer	0.00183	0.00995	CcSEcCtD
Fidaxomicin—Vomiting—Floxuridine—stomach cancer	0.00175	0.00953	CcSEcCtD
Fidaxomicin—Rash—Floxuridine—stomach cancer	0.00173	0.00945	CcSEcCtD
Fidaxomicin—Dermatitis—Floxuridine—stomach cancer	0.00173	0.00944	CcSEcCtD
Fidaxomicin—Headache—Floxuridine—stomach cancer	0.00172	0.00939	CcSEcCtD
Fidaxomicin—Abdominal distension—Irinotecan—stomach cancer	0.00166	0.00904	CcSEcCtD
Fidaxomicin—Nausea—Floxuridine—stomach cancer	0.00163	0.0089	CcSEcCtD
Fidaxomicin—Dysphagia—Fluorouracil—stomach cancer	0.00158	0.0086	CcSEcCtD
Fidaxomicin—Neutropenia—Irinotecan—stomach cancer	0.00154	0.0084	CcSEcCtD
Fidaxomicin—Dizziness—Mitomycin—stomach cancer	0.00143	0.00778	CcSEcCtD
Fidaxomicin—Vomiting—Mitomycin—stomach cancer	0.00137	0.00748	CcSEcCtD
Fidaxomicin—Rash—Mitomycin—stomach cancer	0.00136	0.00742	CcSEcCtD
Fidaxomicin—Dermatitis—Mitomycin—stomach cancer	0.00136	0.00741	CcSEcCtD
Fidaxomicin—Headache—Mitomycin—stomach cancer	0.00135	0.00737	CcSEcCtD
Fidaxomicin—Gastrointestinal haemorrhage—Docetaxel—stomach cancer	0.00132	0.00718	CcSEcCtD
Fidaxomicin—Nausea—Mitomycin—stomach cancer	0.00128	0.00699	CcSEcCtD
Fidaxomicin—Gastrointestinal haemorrhage—Capecitabine—stomach cancer	0.00128	0.00696	CcSEcCtD
Fidaxomicin—Immune system disorder—Irinotecan—stomach cancer	0.00119	0.00649	CcSEcCtD
Fidaxomicin—Alanine aminotransferase increased—Docetaxel—stomach cancer	0.00116	0.00634	CcSEcCtD
Fidaxomicin—Dysphagia—Docetaxel—stomach cancer	0.00114	0.00621	CcSEcCtD
Fidaxomicin—Flatulence—Irinotecan—stomach cancer	0.00113	0.00617	CcSEcCtD
Fidaxomicin—Alanine aminotransferase increased—Capecitabine—stomach cancer	0.00113	0.00613	CcSEcCtD
Fidaxomicin—Abdominal distension—Capecitabine—stomach cancer	0.00111	0.00605	CcSEcCtD
Fidaxomicin—Dysphagia—Capecitabine—stomach cancer	0.0011	0.00601	CcSEcCtD
Fidaxomicin—Neutropenia—Docetaxel—stomach cancer	0.00107	0.00581	CcSEcCtD
Fidaxomicin—Anaemia—Irinotecan—stomach cancer	0.00106	0.00578	CcSEcCtD
Fidaxomicin—Neutropenia—Capecitabine—stomach cancer	0.00103	0.00562	CcSEcCtD
Fidaxomicin—Anaemia—Fluorouracil—stomach cancer	0.00102	0.00554	CcSEcCtD
Fidaxomicin—Hyperglycaemia—Capecitabine—stomach cancer	0.000995	0.00542	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Docetaxel—stomach cancer	0.000961	0.00524	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Capecitabine—stomach cancer	0.000931	0.00507	CcSEcCtD
Fidaxomicin—Nervous system disorder—Irinotecan—stomach cancer	0.00092	0.00501	CcSEcCtD
Fidaxomicin—Gastrointestinal haemorrhage—Epirubicin—stomach cancer	0.00089	0.00485	CcSEcCtD
Fidaxomicin—Nervous system disorder—Fluorouracil—stomach cancer	0.000881	0.0048	CcSEcCtD
Fidaxomicin—Dyspnoea—Irinotecan—stomach cancer	0.000836	0.00455	CcSEcCtD
Fidaxomicin—Dyspepsia—Irinotecan—stomach cancer	0.000825	0.0045	CcSEcCtD
Fidaxomicin—Immune system disorder—Docetaxel—stomach cancer	0.000824	0.00449	CcSEcCtD
Fidaxomicin—Gastrointestinal haemorrhage—Doxorubicin—stomach cancer	0.000823	0.00448	CcSEcCtD
Fidaxomicin—Decreased appetite—Irinotecan—stomach cancer	0.000815	0.00444	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Irinotecan—stomach cancer	0.00081	0.00441	CcSEcCtD
Fidaxomicin—Constipation—Irinotecan—stomach cancer	0.000802	0.00437	CcSEcCtD
Fidaxomicin—Dyspnoea—Fluorouracil—stomach cancer	0.000801	0.00436	CcSEcCtD
Fidaxomicin—Immune system disorder—Capecitabine—stomach cancer	0.000798	0.00435	CcSEcCtD
Fidaxomicin—Malnutrition—Docetaxel—stomach cancer	0.000794	0.00433	CcSEcCtD
Fidaxomicin—Dyspepsia—Fluorouracil—stomach cancer	0.000791	0.00431	CcSEcCtD
Fidaxomicin—Alanine aminotransferase increased—Epirubicin—stomach cancer	0.000785	0.00427	CcSEcCtD
Fidaxomicin—Decreased appetite—Fluorouracil—stomach cancer	0.000781	0.00425	CcSEcCtD
Fidaxomicin—Dysgeusia—Docetaxel—stomach cancer	0.000778	0.00424	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000775	0.00422	CcSEcCtD
Fidaxomicin—Abdominal distension—Epirubicin—stomach cancer	0.000774	0.00422	CcSEcCtD
Fidaxomicin—Malnutrition—Capecitabine—stomach cancer	0.000769	0.00419	CcSEcCtD
Fidaxomicin—Dysphagia—Epirubicin—stomach cancer	0.000769	0.00419	CcSEcCtD
Fidaxomicin—Neutropenia—Methotrexate—stomach cancer	0.000768	0.00418	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Irinotecan—stomach cancer	0.000767	0.00418	CcSEcCtD
Fidaxomicin—Flatulence—Capecitabine—stomach cancer	0.000758	0.00413	CcSEcCtD
Fidaxomicin—Dysgeusia—Capecitabine—stomach cancer	0.000753	0.0041	CcSEcCtD
Fidaxomicin—Abdominal pain—Irinotecan—stomach cancer	0.000741	0.00404	CcSEcCtD
Fidaxomicin—Anaemia—Docetaxel—stomach cancer	0.000734	0.004	CcSEcCtD
Fidaxomicin—Alanine aminotransferase increased—Doxorubicin—stomach cancer	0.000726	0.00395	CcSEcCtD
Fidaxomicin—Neutropenia—Epirubicin—stomach cancer	0.000719	0.00392	CcSEcCtD
Fidaxomicin—Abdominal distension—Doxorubicin—stomach cancer	0.000716	0.0039	CcSEcCtD
Fidaxomicin—Dysphagia—Doxorubicin—stomach cancer	0.000711	0.00388	CcSEcCtD
Fidaxomicin—Anaemia—Capecitabine—stomach cancer	0.000711	0.00387	CcSEcCtD
Fidaxomicin—Hyperglycaemia—Epirubicin—stomach cancer	0.000694	0.00378	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Methotrexate—stomach cancer	0.000693	0.00377	CcSEcCtD
Fidaxomicin—Hypersensitivity—Irinotecan—stomach cancer	0.000691	0.00376	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000672	0.00366	CcSEcCtD
Fidaxomicin—Neutropenia—Doxorubicin—stomach cancer	0.000665	0.00362	CcSEcCtD
Fidaxomicin—Hypersensitivity—Fluorouracil—stomach cancer	0.000662	0.0036	CcSEcCtD
Fidaxomicin—Dry mouth—Docetaxel—stomach cancer	0.000661	0.0036	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.00065	0.00354	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Epirubicin—stomach cancer	0.000648	0.00353	CcSEcCtD
Fidaxomicin—Hyperglycaemia—Doxorubicin—stomach cancer	0.000642	0.0035	CcSEcCtD
Fidaxomicin—Dry mouth—Capecitabine—stomach cancer	0.00064	0.00349	CcSEcCtD
Fidaxomicin—Nervous system disorder—Docetaxel—stomach cancer	0.000636	0.00346	CcSEcCtD
Fidaxomicin—Pruritus—Fluorouracil—stomach cancer	0.000635	0.00346	CcSEcCtD
Fidaxomicin—Skin disorder—Docetaxel—stomach cancer	0.00063	0.00343	CcSEcCtD
Fidaxomicin—Dizziness—Irinotecan—stomach cancer	0.00062	0.00338	CcSEcCtD
Fidaxomicin—Nervous system disorder—Capecitabine—stomach cancer	0.000615	0.00335	CcSEcCtD
Fidaxomicin—Skin disorder—Capecitabine—stomach cancer	0.00061	0.00332	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Doxorubicin—stomach cancer	0.0006	0.00327	CcSEcCtD
Fidaxomicin—Vomiting—Irinotecan—stomach cancer	0.000596	0.00325	CcSEcCtD
Fidaxomicin—Immune system disorder—Methotrexate—stomach cancer	0.000594	0.00324	CcSEcCtD
Fidaxomicin—Dizziness—Fluorouracil—stomach cancer	0.000594	0.00323	CcSEcCtD
Fidaxomicin—Rash—Irinotecan—stomach cancer	0.000591	0.00322	CcSEcCtD
Fidaxomicin—Dermatitis—Irinotecan—stomach cancer	0.000591	0.00322	CcSEcCtD
Fidaxomicin—Headache—Irinotecan—stomach cancer	0.000587	0.0032	CcSEcCtD
Fidaxomicin—Dyspnoea—Docetaxel—stomach cancer	0.000578	0.00315	CcSEcCtD
Fidaxomicin—Malnutrition—Methotrexate—stomach cancer	0.000572	0.00312	CcSEcCtD
Fidaxomicin—Vomiting—Fluorouracil—stomach cancer	0.000571	0.00311	CcSEcCtD
Fidaxomicin—Dyspepsia—Docetaxel—stomach cancer	0.000571	0.00311	CcSEcCtD
Fidaxomicin—Rash—Fluorouracil—stomach cancer	0.000566	0.00308	CcSEcCtD
Fidaxomicin—Dermatitis—Fluorouracil—stomach cancer	0.000566	0.00308	CcSEcCtD
Fidaxomicin—Decreased appetite—Docetaxel—stomach cancer	0.000563	0.00307	CcSEcCtD
Fidaxomicin—Headache—Fluorouracil—stomach cancer	0.000563	0.00306	CcSEcCtD
Fidaxomicin—Dysgeusia—Methotrexate—stomach cancer	0.000561	0.00305	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Docetaxel—stomach cancer	0.00056	0.00305	CcSEcCtD
Fidaxomicin—Dyspnoea—Capecitabine—stomach cancer	0.000559	0.00305	CcSEcCtD
Fidaxomicin—Nausea—Irinotecan—stomach cancer	0.000557	0.00303	CcSEcCtD
Fidaxomicin—Immune system disorder—Epirubicin—stomach cancer	0.000556	0.00303	CcSEcCtD
Fidaxomicin—Constipation—Docetaxel—stomach cancer	0.000554	0.00302	CcSEcCtD
Fidaxomicin—Dyspepsia—Capecitabine—stomach cancer	0.000552	0.00301	CcSEcCtD
Fidaxomicin—Decreased appetite—Capecitabine—stomach cancer	0.000546	0.00297	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000542	0.00295	CcSEcCtD
Fidaxomicin—Constipation—Capecitabine—stomach cancer	0.000537	0.00292	CcSEcCtD
Fidaxomicin—Malnutrition—Epirubicin—stomach cancer	0.000536	0.00292	CcSEcCtD
Fidaxomicin—Nausea—Fluorouracil—stomach cancer	0.000533	0.00291	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Docetaxel—stomach cancer	0.00053	0.00289	CcSEcCtD
Fidaxomicin—Anaemia—Methotrexate—stomach cancer	0.000529	0.00288	CcSEcCtD
Fidaxomicin—Flatulence—Epirubicin—stomach cancer	0.000528	0.00288	CcSEcCtD
Fidaxomicin—Dysgeusia—Epirubicin—stomach cancer	0.000525	0.00286	CcSEcCtD
Fidaxomicin—Immune system disorder—Doxorubicin—stomach cancer	0.000514	0.0028	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Capecitabine—stomach cancer	0.000513	0.0028	CcSEcCtD
Fidaxomicin—Abdominal pain—Docetaxel—stomach cancer	0.000512	0.00279	CcSEcCtD
Fidaxomicin—Abdominal pain—Capecitabine—stomach cancer	0.000496	0.0027	CcSEcCtD
Fidaxomicin—Malnutrition—Doxorubicin—stomach cancer	0.000496	0.0027	CcSEcCtD
Fidaxomicin—Anaemia—Epirubicin—stomach cancer	0.000495	0.0027	CcSEcCtD
Fidaxomicin—Flatulence—Doxorubicin—stomach cancer	0.000488	0.00266	CcSEcCtD
Fidaxomicin—Dysgeusia—Doxorubicin—stomach cancer	0.000485	0.00264	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000484	0.00264	CcSEcCtD
Fidaxomicin—Hypersensitivity—Docetaxel—stomach cancer	0.000478	0.0026	CcSEcCtD
Fidaxomicin—Hypersensitivity—Capecitabine—stomach cancer	0.000462	0.00252	CcSEcCtD
Fidaxomicin—Pruritus—Docetaxel—stomach cancer	0.000459	0.0025	CcSEcCtD
Fidaxomicin—Nervous system disorder—Methotrexate—stomach cancer	0.000458	0.0025	CcSEcCtD
Fidaxomicin—Anaemia—Doxorubicin—stomach cancer	0.000458	0.0025	CcSEcCtD
Fidaxomicin—Skin disorder—Methotrexate—stomach cancer	0.000454	0.00247	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000453	0.00247	CcSEcCtD
Fidaxomicin—Dry mouth—Epirubicin—stomach cancer	0.000446	0.00243	CcSEcCtD
Fidaxomicin—Pruritus—Capecitabine—stomach cancer	0.000444	0.00242	CcSEcCtD
Fidaxomicin—Nervous system disorder—Epirubicin—stomach cancer	0.000429	0.00234	CcSEcCtD
Fidaxomicin—Dizziness—Docetaxel—stomach cancer	0.000429	0.00233	CcSEcCtD
Fidaxomicin—Skin disorder—Epirubicin—stomach cancer	0.000425	0.00231	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000419	0.00228	CcSEcCtD
Fidaxomicin—Dyspnoea—Methotrexate—stomach cancer	0.000417	0.00227	CcSEcCtD
Fidaxomicin—Dizziness—Capecitabine—stomach cancer	0.000415	0.00226	CcSEcCtD
Fidaxomicin—Dry mouth—Doxorubicin—stomach cancer	0.000413	0.00225	CcSEcCtD
Fidaxomicin—Vomiting—Docetaxel—stomach cancer	0.000412	0.00224	CcSEcCtD
Fidaxomicin—Dyspepsia—Methotrexate—stomach cancer	0.000411	0.00224	CcSEcCtD
Fidaxomicin—Rash—Docetaxel—stomach cancer	0.000409	0.00223	CcSEcCtD
Fidaxomicin—Dermatitis—Docetaxel—stomach cancer	0.000408	0.00222	CcSEcCtD
Fidaxomicin—Decreased appetite—Methotrexate—stomach cancer	0.000406	0.00221	CcSEcCtD
Fidaxomicin—Headache—Docetaxel—stomach cancer	0.000406	0.00221	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000403	0.0022	CcSEcCtD
Fidaxomicin—Vomiting—Capecitabine—stomach cancer	0.000399	0.00217	CcSEcCtD
Fidaxomicin—Nervous system disorder—Doxorubicin—stomach cancer	0.000397	0.00216	CcSEcCtD
Fidaxomicin—Rash—Capecitabine—stomach cancer	0.000396	0.00216	CcSEcCtD
Fidaxomicin—Dermatitis—Capecitabine—stomach cancer	0.000395	0.00215	CcSEcCtD
Fidaxomicin—Headache—Capecitabine—stomach cancer	0.000393	0.00214	CcSEcCtD
Fidaxomicin—Skin disorder—Doxorubicin—stomach cancer	0.000393	0.00214	CcSEcCtD
Fidaxomicin—Dyspnoea—Epirubicin—stomach cancer	0.00039	0.00212	CcSEcCtD
Fidaxomicin—Nausea—Docetaxel—stomach cancer	0.000385	0.0021	CcSEcCtD
Fidaxomicin—Dyspepsia—Epirubicin—stomach cancer	0.000385	0.0021	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Methotrexate—stomach cancer	0.000382	0.00208	CcSEcCtD
Fidaxomicin—Decreased appetite—Epirubicin—stomach cancer	0.00038	0.00207	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000377	0.00206	CcSEcCtD
Fidaxomicin—Constipation—Epirubicin—stomach cancer	0.000374	0.00204	CcSEcCtD
Fidaxomicin—Nausea—Capecitabine—stomach cancer	0.000373	0.00203	CcSEcCtD
Fidaxomicin—Abdominal pain—Methotrexate—stomach cancer	0.000369	0.00201	CcSEcCtD
Fidaxomicin—Dyspnoea—Doxorubicin—stomach cancer	0.000361	0.00196	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Epirubicin—stomach cancer	0.000358	0.00195	CcSEcCtD
Fidaxomicin—Dyspepsia—Doxorubicin—stomach cancer	0.000356	0.00194	CcSEcCtD
Fidaxomicin—Decreased appetite—Doxorubicin—stomach cancer	0.000352	0.00192	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000349	0.0019	CcSEcCtD
Fidaxomicin—Constipation—Doxorubicin—stomach cancer	0.000346	0.00188	CcSEcCtD
Fidaxomicin—Abdominal pain—Epirubicin—stomach cancer	0.000346	0.00188	CcSEcCtD
Fidaxomicin—Hypersensitivity—Methotrexate—stomach cancer	0.000344	0.00187	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000331	0.0018	CcSEcCtD
Fidaxomicin—Pruritus—Methotrexate—stomach cancer	0.000331	0.0018	CcSEcCtD
Fidaxomicin—Hypersensitivity—Epirubicin—stomach cancer	0.000322	0.00175	CcSEcCtD
Fidaxomicin—Abdominal pain—Doxorubicin—stomach cancer	0.00032	0.00174	CcSEcCtD
Fidaxomicin—Pruritus—Epirubicin—stomach cancer	0.000309	0.00168	CcSEcCtD
Fidaxomicin—Dizziness—Methotrexate—stomach cancer	0.000309	0.00168	CcSEcCtD
Fidaxomicin—Hypersensitivity—Doxorubicin—stomach cancer	0.000298	0.00162	CcSEcCtD
Fidaxomicin—Vomiting—Methotrexate—stomach cancer	0.000297	0.00162	CcSEcCtD
Fidaxomicin—Rash—Methotrexate—stomach cancer	0.000295	0.0016	CcSEcCtD
Fidaxomicin—Dermatitis—Methotrexate—stomach cancer	0.000294	0.0016	CcSEcCtD
Fidaxomicin—Headache—Methotrexate—stomach cancer	0.000293	0.00159	CcSEcCtD
Fidaxomicin—Dizziness—Epirubicin—stomach cancer	0.000289	0.00157	CcSEcCtD
Fidaxomicin—Pruritus—Doxorubicin—stomach cancer	0.000286	0.00156	CcSEcCtD
Fidaxomicin—Vomiting—Epirubicin—stomach cancer	0.000278	0.00151	CcSEcCtD
Fidaxomicin—Nausea—Methotrexate—stomach cancer	0.000277	0.00151	CcSEcCtD
Fidaxomicin—Rash—Epirubicin—stomach cancer	0.000276	0.0015	CcSEcCtD
Fidaxomicin—Dermatitis—Epirubicin—stomach cancer	0.000275	0.0015	CcSEcCtD
Fidaxomicin—Headache—Epirubicin—stomach cancer	0.000274	0.00149	CcSEcCtD
Fidaxomicin—Dizziness—Doxorubicin—stomach cancer	0.000268	0.00146	CcSEcCtD
Fidaxomicin—Nausea—Epirubicin—stomach cancer	0.00026	0.00141	CcSEcCtD
Fidaxomicin—Vomiting—Doxorubicin—stomach cancer	0.000257	0.0014	CcSEcCtD
Fidaxomicin—Rash—Doxorubicin—stomach cancer	0.000255	0.00139	CcSEcCtD
Fidaxomicin—Dermatitis—Doxorubicin—stomach cancer	0.000255	0.00139	CcSEcCtD
Fidaxomicin—Headache—Doxorubicin—stomach cancer	0.000253	0.00138	CcSEcCtD
Fidaxomicin—Nausea—Doxorubicin—stomach cancer	0.00024	0.00131	CcSEcCtD
